| Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike J Prévost, R Gasser, G Beaudoin-Bussières, J Richard, R Duerr, ... Cell Reports Medicine 1 (7), 2020 | 236 | 2020 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 207 | 2021 |
| Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy I Ullah, J Prévost, MS Ladinsky, H Stone, M Lu, SP Anand, ... Immunity 54 (9), 2143-2158. e15, 2021 | 199 | 2021 |
| Real-time conformational dynamics of SARS-CoV-2 spikes on virus particles M Lu, PD Uchil, W Li, D Zheng, DS Terry, J Gorman, W Shi, B Zhang, ... Cell host & microbe 28 (6), 880-891. e8, 2020 | 186 | 2020 |
| Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, ... MBio 11 (5), 10.1128/mbio. 02590-20, 2020 | 185 | 2020 |
| Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset SP Anand, J Prévost, M Nayrac, G Beaudoin-Bussières, M Benlarbi, ... Cell Reports Medicine 2 (6), 2021 | 183 | 2021 |
| A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 173 | 2021 |
| Vaccine-induced protection from homologous tier 2 SHIV challenge in nonhuman primates depends on serum-neutralizing antibody titers MG Pauthner, JP Nkolola, C Havenar-Daughton, B Murrell, SM Reiss, ... Immunity 50 (1), 241-252. e6, 2019 | 152 | 2019 |
| Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset J Perreault, T Tremblay, MJ Fournier, M Drouin, G Beaudoin-Bussières, ... Blood, The Journal of the American Society of Hematology 136 (22), 2588-2591, 2020 | 136 | 2020 |
| Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern W Li, Y Chen, J Prévost, I Ullah, M Lu, SY Gong, A Tauzin, R Gasser, ... Cell reports 38 (2), 2022 | 116 | 2022 |
| Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 R Gasser, M Cloutier, J Prévost, C Fink, É Ducas, S Ding, N Dussault, ... Cell reports 34 (9), 2021 | 116 | 2021 |
| A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection G Beaudoin-Bussières, Y Chen, I Ullah, J Prévost, WD Tolbert, K Symmes, ... Cell reports 38 (7), 2022 | 108 | 2022 |
| An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity N Alsahafi, N Bakouche, M Kazemi, J Richard, S Ding, S Bhattacharyya, ... Cell host & microbe 25 (4), 578-587. e5, 2019 | 105 | 2019 |
| Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity SY Gong, D Chatterjee, J Richard, J Prévost, A Tauzin, R Gasser, Y Bo, ... Virology 563, 134-145, 2021 | 95 | 2021 |
| The great escape? SARS-CoV-2 variants evading neutralizing responses J Prévost, A Finzi Cell Host & Microbe 29 (3), 322-324, 2021 | 91 | 2021 |
| Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses A Tauzin, SY Gong, G Beaudoin-Bussières, D Vézina, R Gasser, L Nault, ... Cell host & microbe 30 (1), 97-109. e5, 2022 | 88 | 2022 |
| Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses J Richard, J Prevost, AE Baxter, B von Bredow, S Ding, H Medjahed, ... MBio 9 (2), 10.1128/mbio. 00358-18, 2018 | 85 | 2018 |
| Impact of HIV-1 envelope conformation on ADCC responses J Richard, J Prévost, N Alsahafi, S Ding, A Finzi Trends in microbiology 26 (4), 253-265, 2018 | 79 | 2018 |
| Co-receptor binding site antibodies enable CD4-mimetics to expose conserved anti-cluster A ADCC epitopes on HIV-1 envelope glycoproteins J Richard, B Pacheco, N Gohain, M Veillette, S Ding, N Alsahafi, ... EBioMedicine 12, 208-218, 2016 | 74 | 2016 |
| A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster A antibodies S Ding, M Veillette, M Coutu, J Prévost, L Scharf, PJ Bjorkman, G Ferrari, ... Journal of virology 90 (4), 2127-2134, 2016 | 74 | 2016 |
Andrés FinziUniversité de Montréal / CRCHUMGeverifieerd e-mailadres voor umontreal.ca
